These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 34825802)

  • 1. Health-related Quality of Life after a one-year follow-up of patients undergoing endovascular leg revascularization.
    Banaś W; Wiśniewska J; Mieczkowski A; Czerniak B; Budzyński J
    Int Angiol; 2022 Feb; 41(1):48-55. PubMed ID: 34825802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and psychological functioning of patients with chronic limb ischemia during a 1-year period after endovascular revascularization.
    Banaś W; Czerniak B; Budzyński J
    J Vasc Surg; 2022 May; 75(5):1679-1686. PubMed ID: 34695554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP; Schanzer A; Flahive JM; Osborne NH; Mills JL; Bradbury AW; Conte MS
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S120-S134.e3. PubMed ID: 31151867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trial.
    Siracuse JJ; Rowe VL; Menard MT; Rosenfield K; Conte MS; Powell R; Clavijo LC; Giles KA; Hamza TH; Van Over M; Cziraky M; White CJ; Strong MB; Farber A
    J Vasc Surg; 2023 Apr; 77(4):1099-1106.e4. PubMed ID: 36435274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S110-S119. PubMed ID: 31221539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    Conte MS; Bradbury AW; Kolh P; White JV; Dick F; Fitridge R; Mills JL; Ricco JB; Suresh KR; Murad MH; Aboyans V; Aksoy M; Alexandrescu VA; Armstrong D; Azuma N; Belch J; Bergoeing M; Bjorck M; Chakfé N; Cheng S; Dawson J; Debus ES; Dueck A; Duval S; Eckstein HH; Ferraresi R; Gambhir R; Gargiulo M; Geraghty P; Goode S; Gray B; Guo W; Gupta PC; Hinchliffe R; Jetty P; Komori K; Lavery L; Liang W; Lookstein R; Menard M; Misra S; Miyata T; Moneta G; Munoa Prado JA; Munoz A; Paolini JE; Patel M; Pomposelli F; Powell R; Robless P; Rogers L; Schanzer A; Schneider P; Taylor S; De Ceniga MV; Veller M; Vermassen F; Wang J; Wang S;
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S1-S109.e33. PubMed ID: 31182334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trial.
    Magnuson EA; Li H; Vilain K; Armstrong EJ; Secemsky EA; Giannopoulos S; Adams GL; Mustapha J; Cohen DJ;
    J Med Econ; 2021; 24(1):570-580. PubMed ID: 33866936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T; Kichikawa K; Yokoi H; Iida O; Yamaoka T; Maeda K; Kanaoka Y
    J Vasc Surg; 2021 Dec; 74(6):1958-1967.e2. PubMed ID: 34182032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a Medical vs Revascularization Intervention for Intermittent Leg Claudication Based on Patient-Reported Outcomes.
    Devine EB; Alfonso-Cristancho R; Yanez ND; Edwards TC; Patrick DL; Armstrong CA; Devlin A; Symons RG; Meissner MH; Derrick EL; Lavallee DC; Kessler LG; Flum DR;
    JAMA Surg; 2016 Oct; 151(10):e162024. PubMed ID: 27760274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Stenting of the Superficial Femoral Artery in Intermittent Claudication Improves Health Related Quality of Life, ABI and Walking Distance: 12 Month Results of a Controlled Randomised Multicentre Trial.
    Lindgren H; Qvarfordt P; Åkesson M; Bergman S; Gottsäter A;
    Eur J Vasc Endovasc Surg; 2017 May; 53(5):686-694. PubMed ID: 28372983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a Good Quality of Life and Health Status Possible in Older Patients Dying from Critical Limb-Threatening Ischemia: A Prospective Clinical Study.
    Peters CML; de Vries J; Lodder P; van der Laan L
    Ann Vasc Surg; 2020 Apr; 64():198-201. PubMed ID: 31639483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.
    Kim TI; Brahmandam A; Sarac TP; Orion KC
    Vasc Med; 2020 Dec; 25(6):527-533. PubMed ID: 33019909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.
    Fakhry F; Spronk S; van der Laan L; Wever JJ; Teijink JA; Hoffmann WH; Smits TM; van Brussel JP; Stultiens GN; Derom A; den Hoed PT; Ho GH; van Dijk LC; Verhofstad N; Orsini M; van Petersen A; Woltman K; Hulst I; van Sambeek MR; Rizopoulos D; Rouwet EV; Hunink MG
    JAMA; 2015 Nov; 314(18):1936-44. PubMed ID: 26547465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcomes of lower extremity revascularization: What role do race, ethnicity, and socioeconomic status play?
    Robinson WP
    Semin Vasc Surg; 2023 Mar; 36(1):69-77. PubMed ID: 36958900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular intervention for peripheral artery disease.
    Thukkani AK; Kinlay S
    Circ Res; 2015 Apr; 116(9):1599-613. PubMed ID: 25908731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of revascularization on lower extremity muscle function in combined type 2 diabetes and critical limb threatening ischemia.
    Pedersen BL; Helledie G; Eiken FL; Lawaetz J; Eiberg JP; Quistorff B
    Int Angiol; 2021 Aug; 40(4):323-334. PubMed ID: 34008931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threatening ischemia.
    Krievins D; Zellans E; Latkovskis G; Kumsars I; Jegere S; Rumba R; Bruvere M; Zarins CK
    J Vasc Surg; 2021 Oct; 74(4):1261-1271. PubMed ID: 33905868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.
    Biscetti F; Nardella E; Rando MM; Cecchini AL; Gasbarrini A; Massetti M; Flex A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.